Reuter James Wealth Management, LLC Gilead Sciences, Inc. Transaction History
Reuter James Wealth Management, LLC
- $536 Million
- Q4 2024
A detailed history of Reuter James Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 13,270 shares of GILD stock, worth $1.43 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
13,270
Previous 15,144
12.37%
Holding current value
$1.43 Million
Previous $1.27 Million
3.47%
% of portfolio
0.23%
Previous 0.24%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,086Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.4 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.72 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.5 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.24 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...